Processes downstream of IRS-2, but independent of PI3K, that promote breast cancer invasion have not yet been extensively investigated, and future studies examining these mechanisms may reveal novel approaches for targeting IGF-1R signaling in breast cancer. The gene discussed is IRS2; the disease is breast carcinoma.